Jesse Courtier, MD

CA3D+ Co-Director
CHO Administration
+1 415 476-1364

Jesse Courtier, MD, is the Chief of Pediatric Radiology at UCSF Benioff Children's Hospital, San Francisco, and a Clinical Professor in the UCSF Department of Radiology & Biomedical Imaging. He is responsible for the interpretation of pediatric imaging using multiple modalities including CT, MRI, ultrasound, plain film and fluoroscopy for the thoracic, abdominal/pelvic, and musculoskeletal systems in Pediatric patients.

Dr. Courtier obtained his medical degree from the University of Iowa College of Medicine in 2003 and completed his residency in Diagnostic Radiology at the University of Kansas, Wichita in 2008, followed by fellowships in Abdominal Imaging and Pediatric Radiology at UCSF.

Dr. Courtier’s primary research interests include the investigation of augmented reality applications in medical imaging for use in training and surgical planning, and technique optimization in pediatric body MR applications including MR urography, MR enterography, and fetal MR.

Dr. Courtier has key interests in medical education and has served as the Diagnostic Radiology Residency Site Director of Training for the Mission Bay Hospital, Director of the Pediatric Radiology Fellowship, and Chair of the Radiology Residency Clinical Competency Committee.

He has published 46+ peer-review journal articles as well as several abstracts and educational exhibits. Dr. Courtier is an award-winning educator. He is a past recipient of the Department of Radiology Outstanding Fellow Teaching Award, the Haile T Debas Excellence in Teaching Award, and the Department of Radiology Hideyo Minagi Teaching Award.

Expertise:
Pediatric Radiology; Augmented Reality

Specialty:
CT, MRI, ultrasound, plain film and fluoroscopy in the thoracic, abdominal/pelvic, and musculoskeletal organ systems of pediatric patients

Professional Interests:
Pediatric body MRI, MR enterography, pediatric oncologic imaging, fetal MRI, 3D printing and post-processing, Augmented Reality applications

Education and Training:
• Medical School: University of Iowa College of Medicine, Iowa City
• Internship: University of Hawaii, Honolulu - Preliminary Surgery
• Residency: University of Kansas, Wichita - Diagnostic Radiology
• Fellowship: University of California, San Francisco Department of Radiology and Biomedical Imaging - Abdominal Imaging
• Fellowship: University of California, San Francisco Department of Radiology and Biomedical Imaging - Pediatric Radiology
• State of California Medical License
• Diplomate, American Board of Radiology
• Pediatric Advanced Life Support
• Basic Life Support for Health Care Providers
• CAQ (Certificate of Additional Qualification) in Pediatric Radiology

Publications

Phase II Trial of Alisertib in Combination with Irinotecan and Temozolomide for Patients with Relapsed or Refractory Neuroblastoma.

Clinical cancer research : an official journal of the American Association for Cancer Research

DuBois SG, Mosse YP, Fox E, Kudgus RA, Reid JM, McGovern R, Groshen S, Bagatell R, Maris JM, Twist CJ, Goldsmith K, Granger MM, Weiss B, Park JR, Macy ME, Cohn SL, Yanik G, Wagner LM, Hawkins R, Courtier J, Lai H, Goodarzian F, Shimada H, Boucher N, Czarnecki S, Luo C, Tsao-Wei D, Matthay KK, Marachelian A

Phase II study of alisertib, irinotecan, and temozolomide in children with relapsed and refractory neuroblastoma: A report from the New Approaches to Neuroblastoma Therapy (NANT) consortium.

Journal of Clinical Oncology

Steven G. DuBois, Araz Marachelian, Elizabeth Fox, Rachel A. Kudgus, Joel M. Reid, Susan G. Groshen, Jemily Malvar, Rochelle Bagatell, Lars M. Wagner, John M. Maris, Randall Hawkins, Jesse Courtier, Hollie Lai, Fariba Goodarzian, Hiroyuki Shimada, Najee Boucher, Scarlett Czarnecki, Denice D Tsao-Wei, Katherine K. Matthay, Yael P. Mosse

Phase I Study of the Aurora A Kinase Inhibitor Alisertib in Combination With Irinotecan and Temozolomide for Patients With Relapsed or Refractory Neuroblastoma: A NANT (New Approaches to Neuroblastoma Therapy) Trial.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

DuBois SG, Marachelian A, Fox E, Kudgus RA, Reid JM, Groshen S, Malvar J, Bagatell R, Wagner L, Maris JM, Hawkins R, Courtier J, Lai H, Goodarzian F, Shimada H, Czarnecki S, Tsao-Wei D, Matthay KK, Mosse YP

Scrotal swelling in the neonate.

Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine

Basta AM, Courtier J, Phelps A, Copp HL, MacKenzie JD

Phase I Study of Vorinostat as a Radiation Sensitizer with 131I-Metaiodobenzylguanidine (131I-MIBG) for Patients with Relapsed or Refractory Neuroblastoma.

Clinical cancer research : an official journal of the American Association for Cancer Research

DuBois SG, Groshen S, Park JR, Haas-Kogan DA, Yang X, Geier E, Chen E, Giacomini K, Weiss B, Cohn SL, Granger MM, Yanik GA, Hawkins R, Courtier J, Jackson H, Goodarzian F, Shimada H, Czarnecki S, Tsao-Wei D, Villablanca JG, Marachelian A, Matthay KK

131I-metaiodobenzylguanidine with intensive chemotherapy and autologous stem cell transplantation for high-risk neuroblastoma. A new approaches to neuroblastoma therapy (NANT) phase II study.

Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation

Yanik GA, Villablanca JG, Maris JM, Weiss B, Groshen S, Marachelian A, Park JR, Tsao-Wei D, Hawkins R, Shulkin BL, Jackson H, Goodarzian F, Shimada H, Courtier J, Hutchinson R, Haas-Koga D, Hasenauer CB, Czarnecki S, Katzenstein HM, Matthay KK